Upload File

acute heart failure management guidelinesaki or significant ckd 5.0 hx of angioedema (acei) hold for...

  • Home
  • Documents
  • Acute Heart Failure Management GuidelinesAKI or significant CKD 5.0 Hx of angioedema (ACEI) Hold for anesthesia & dye studies AKI or significant CKD or K > 5.0 ACEI within 36 hrs
12
Acute Heart Failure Management Guidelines

Upload: others

Post on 08-Jan-2020

2 views

Category:

Documents


0 download

Report

TRANSCRIPT

Page 1: Acute Heart Failure Management GuidelinesAKI or significant CKD 5.0 Hx of angioedema (ACEI) Hold for anesthesia & dye studies AKI or significant CKD or K > 5.0 ACEI within 36 hrs

Acute Heart Failure Management Guidelines

Page 2: Acute Heart Failure Management GuidelinesAKI or significant CKD 5.0 Hx of angioedema (ACEI) Hold for anesthesia & dye studies AKI or significant CKD or K > 5.0 ACEI within 36 hrs

BackgroundMulti-disciplinary group convened to address the

challenges in caring for heart failure patients

This collaborative regional team focused on:–Improvement of our NYP Heart Failure services–Patient and physician education–Online resources–Innovation around transitions of care

2

Page 3: Acute Heart Failure Management GuidelinesAKI or significant CKD 5.0 Hx of angioedema (ACEI) Hold for anesthesia & dye studies AKI or significant CKD or K > 5.0 ACEI within 36 hrs

Purpose of CHF Management GuidelinesStandardize CHF Care across NYP’s 8 Hospital System

Provide excellent care to all heart failure patients admitted to the hospital through:–Decongestion with intravenous diuretics–Rapid evaluation for decompensation–Guidance for cardiology and/or heart failure

consultation/referral –Discharge planning

3

Page 4: Acute Heart Failure Management GuidelinesAKI or significant CKD 5.0 Hx of angioedema (ACEI) Hold for anesthesia & dye studies AKI or significant CKD or K > 5.0 ACEI within 36 hrs

Standardized Yet Campus Specific

4

• Heart Failure Management Guidelines cards are campus specific

• Medications listed reflect campus formulary

• Accurate phone and beeper numbers for cardiology and advanced heart failure consults and referrals

Page 5: Acute Heart Failure Management GuidelinesAKI or significant CKD 5.0 Hx of angioedema (ACEI) Hold for anesthesia & dye studies AKI or significant CKD or K > 5.0 ACEI within 36 hrs
Page 6: Acute Heart Failure Management GuidelinesAKI or significant CKD 5.0 Hx of angioedema (ACEI) Hold for anesthesia & dye studies AKI or significant CKD or K > 5.0 ACEI within 36 hrs
Page 7: Acute Heart Failure Management GuidelinesAKI or significant CKD 5.0 Hx of angioedema (ACEI) Hold for anesthesia & dye studies AKI or significant CKD or K > 5.0 ACEI within 36 hrs
Page 8: Acute Heart Failure Management GuidelinesAKI or significant CKD 5.0 Hx of angioedema (ACEI) Hold for anesthesia & dye studies AKI or significant CKD or K > 5.0 ACEI within 36 hrs
Page 9: Acute Heart Failure Management GuidelinesAKI or significant CKD 5.0 Hx of angioedema (ACEI) Hold for anesthesia & dye studies AKI or significant CKD or K > 5.0 ACEI within 36 hrs
Page 10: Acute Heart Failure Management GuidelinesAKI or significant CKD 5.0 Hx of angioedema (ACEI) Hold for anesthesia & dye studies AKI or significant CKD or K > 5.0 ACEI within 36 hrs

Where can I find the card?

10

https://www.nyp.org/heart/chf-hub

Mobile Heartbeat

Physical CardElectronic PDF

Page 11: Acute Heart Failure Management GuidelinesAKI or significant CKD 5.0 Hx of angioedema (ACEI) Hold for anesthesia & dye studies AKI or significant CKD or K > 5.0 ACEI within 36 hrs

11

Page 12: Acute Heart Failure Management GuidelinesAKI or significant CKD 5.0 Hx of angioedema (ACEI) Hold for anesthesia & dye studies AKI or significant CKD or K > 5.0 ACEI within 36 hrs

Thank You

12


中国 ACEI 专家共识 ACEI 在心血管病中应用的专家共识

FACTORES QUE ENMARCAN - ACEI

Dapagliflozin And Prevention of Adverse- outcomes in CKD ... › ... › 430pmET-DAPA-CKD-aha-2020.pdfNov 11, 2020  · DAPA-CKD: Background • Chronic kidney disease (CKD) is an

HTN CKD - KDIGO · Basis for Discontinuing ACEi in Advanced CKD Observational Study • 52 patients (1/2 DM) stages 4 and 5 CKD observed year before and year after stopping ACEi/ARB

CKD & HT...2018/02/22  · • CKD 2 eGFR 60-89 mild • CKD 3a eGFR 45-59 mild-moderate • CKD 3b eGFR 30-44 moderate • CKD 4 eGFR 15-29 severe • CKD 5 eGFR

CKD complications: CKD- MBD and anemia · CKD complications: CKD-MBD and anemia ... In patients with CKD stages 3–5, ... maintenance HD patients prescribed phosphate binders

Reciclagem Felipe Acei

FrontCover Section 7 - Energex...SEC CKD CKD )

1. 2 ACEI inhibit angiotensin converting enzyme in the body. ACEI inhibit angiotensin converting enzyme in the body. Enzyme maintains balance between:

Competencias Educativas del Maestro según diversas entidades: DEPR & ACEI

Kyoto _1a_ ACEI Public Dimensions Srakar Copic

D rossetti acei valladolid 23 6 2016

CKD Corporation · CKD SINGAPORE PTE. LTD. (Singapore) CKD CORPORATION BRANCH OFFICE (Asia Pacific) Singapore CKD India Private Limited (Gurgaon) Bangalore Office India PT CKD TRADING

ACEI Newsletter 19 1

ACEI april 2010

CKD（SHANGHAI） CORPORATION ETV系列 · 電動缸 etv系列 新產品 electric actuator etv series new products taiwan ckd corporation ckd usa corporation ckd uk office ckd europe

6,825B 6,500 // 2013 (DMARDs) CKD 4. 2. CKD 4. CKD 14. 16. 18. … · 2014-10-27 · 6,825B 6,500 // 2013 (DMARDs) CKD 4. 2. CKD 4. CKD 14. 16. 18. 19. 20. 23 24. 25 26. 3. 4. 5

Academic Credentials Evaluation Institute (ACEI)actinternationalservices.com/pdf/ACEI-Letter.pdf · GAC013 GAC027 Electives GAC019 GAC025 Mathematics Il: Probability, Statistics &

POLA PENGGUNAAN OBAT GOLONGAN ACEi DAN ARB PADA

Peranan ACEI Terhadap Gagal Jantung.docx

ACE Inhibitors in CKD Dr Stuart Robertson. Plan Why does CKD matter? Indications for ACEi Assessment & management of proteinuria Mode of action How to

Terry Deary - Acei Azteci Furiosi

Efectes cardiovasculars dels nous fàrmacs antidiabètics ... · ≥2 CV risk factors • HbA1c 7.0–10.5% • Age >30 years • Stage 2 or 3 CKD and microalbumin uria and on ACEi/ARB

Chronic Kidney Disease (CKD) – an introduction CKD - an... · Chronic Kidney Disease (CKD) – an introduction Chronic kidney disease (CKD) is a lifelong condition. The kidneys

CKD and CVD - FOMA District 2 · CKD and CVD • CKD is an independent risk for all types of CVD ... HD population, compared to 12% for CKD only . CKD and CVA • Treatment: -Tx HTN

HYPERTENSION IN CKD - · PDF filebeta-blocker or calcium-channel blocker Blood pressure ACEI or ARB C < 130/80 mmHg and spot urine total protein-to-creatinine ratio ≥200 mg/g Additional

ACEi for Hypertension and compelling.pdf

Presentación de la Candidatura Valladolid ACEI 2016

pathways to peace ACEI presentation

ACEI Irish Water Presentation 03 04 14

RTD CKD rtd ckd dengn datartd ckd dengn datartd ckd dengn data

Beyond ACEI and BB

Angiotensin Converting Enzyme inhibitor (ACEI)

Pathophysiological basis of ACEI, ARBs and CCBs

ACEi in CKD - NHS Wales in CKD.pdfsrobertson.pdf · ACEi are beneficial even in advanced CKD withare beneficial even in advanced CKD with appropriate monitoring Avoid addition of